Title: Colesevelam Hydrochloride and Lanthanum Carbonate Interfere with the Absorption of Levothyroxine
Abstract: ThyroidVol. 19, No. 1 Letters to the EditorColesevelam Hydrochloride and Lanthanum Carbonate Interfere with the Absorption of LevothyroxineSteven P. Weitzman, Karyn C. Ginsburg, and Harold E. CarlsonSteven P. WeitzmanMedical Service, Northport VA Medical Center, Northport, New York.Search for more papers by this author, Karyn C. GinsburgDepartment of Medicine, Division of Endocrinology, Stony Brook University School of Medicine, Stony Brook, New York.Search for more papers by this author, and Harold E. CarlsonDepartment of Medicine, Division of Endocrinology, Stony Brook University School of Medicine, Stony Brook, New York.Search for more papers by this authorPublished Online:2 Jan 2009https://doi.org/10.1089/thy.2008.0312AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookXLinked InRedditEmail FiguresReferencesRelatedDetailsCited byThe Use of Levothyroxine Absorption Tests in Clinical Practice14 March 2023 | The Journal of Clinical Endocrinology & Metabolism, Vol. 108, No. 8A critical review of Roxadustat formulations, solid state studies, and analytical methodologyHeliyon, Vol. 9, No. 6Levothyroxine: Conventional and Novel Drug Delivery Formulations22 November 2022 | Endocrine Reviews, Vol. 44, No. 3Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review1 June 2023 | Therapeutics and Clinical Risk Management, Vol. Volume 19Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption6 December 2022 | Frontiers in Endocrinology, Vol. 13Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults20 October 2021 | Reviews in Endocrine and Metabolic Disorders, Vol. 23, No. 3Gastrointestinal Malabsorption of Thyroxine23 November 2018 | Endocrine Reviews, Vol. 40, No. 1Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature2 July 2018 | BMC Nephrology, Vol. 19, No. 1Evaluation of the effect of lanthanum carbonate hydrate on the pharmacokinetics of roxadustat in non‐elderly healthy adult male subjects7 July 2018 | Journal of Clinical Pharmacy and Therapeutics, Vol. 43, No. 5Concurrent Milk Ingestion Decreases Absorption of Levothyroxine Deborah A. Chon, Tamar Reisman, Jane E. Weinreb, Jerome M. Hershman, and Angela M. Leung1 April 2018 | Thyroid, Vol. 28, No. 4Treatment with Oral Drugs15 March 2018Factors Affecting Gastrointestinal Absorption of Levothyroxine: A ReviewClinical Therapeutics, Vol. 39, No. 2Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification13 May 2016 | Expert Opinion on Pharmacotherapy, Vol. 17, No. 9Hypothyroidism15 March 2016Drug Interactions with Levothyroxine Therapy in Patients with Hypothyroidism: Observational Study in General Practice3 February 2015 | Clinical Drug Investigation, Vol. 35, No. 3Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement Jacqueline Jonklaas, Antonio C. Bianco, Andrew J. Bauer, Kenneth D. Burman, Anne R. Cappola, Francesco S. Celi, David S. Cooper, Brian W. Kim, Robin P. Peeters, M. Sara Rosenthal, and Anna M. Sawka12 December 2014 | Thyroid, Vol. 24, No. 12The Clinical Utility of Free Thyroxine in Oral Levothyroxine Absorption TestingEndocrine Practice, Vol. 20, No. 9Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles5 April 2014 | Expert Opinion on Drug Safety, Vol. 13, No. 5A review of the efficacy and safety of oral antidiabetic drugs14 December 2012 | Expert Opinion on Drug Safety, Vol. 12, No. 2Evaluation of colesevelam hydrochloride for the treatment of type 2 diabetes21 March 2012 | Expert Opinion on Drug Metabolism & Toxicology, Vol. 8, No. 4Carbimazole-Induced Acute Pancreatitis and Cholestatic HepatitisEndocrine Practice, Vol. 17, No. 6Absorption of Levothyroxine When Coadministered with Various Calcium Formulations Isabelle Zamfirescu and Harold E. Carlson19 May 2011 | Thyroid, Vol. 21, No. 5Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular riskFuture Cardiology, Vol. 7, No. 2The Role of Colesevelam Hydrochloride in Hypercholesterolemia and Type 2 Diabetes Mellitus15 June 2010 | Annals of Pharmacotherapy, Vol. 44, No. 7-8Conditions and drugs interfering with thyroxine absorptionBest Practice & Research Clinical Endocrinology & Metabolism, Vol. 23, No. 6 Volume 19Issue 1Jan 2009 InformationCopyright 2009, Mary Ann Liebert, Inc.To cite this article:Steven P. Weitzman, Karyn C. Ginsburg, and Harold E. Carlson.Colesevelam Hydrochloride and Lanthanum Carbonate Interfere with the Absorption of Levothyroxine.Thyroid®.Jan 2009.77-79.http://doi.org/10.1089/thy.2008.0312Published in Volume: 19 Issue 1: January 2, 2009 PDF download